EU biotech champions struggle with finance, says Euronext Brussels CEO | Euractiv

Benoît van den Hove tells Euractiv that scaling biotech companies at a global level still depends on capital that Europe does not yet mobilise at sufficient scale

Raccontata daeuractiv.com